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We need a new paradigm in gynecologic cancer care: SGO proposes solutions for
delivery, quality and reimbursement policiesThe increasingﬁnancial burden of cancer care negatively impacts the
U.S. health care system, our nation's economy, and individuals' quality of
life. More importantly, it contributes signiﬁcantly to premature death.
The current health policy environment for cancer care is built upon a
system that often rewards volume and intensity of therapy rather than
proper coordination and quality of care. Physicians are reimbursed
based on a fee-for-service system that encourages overutilization of
cancer care resources rather than comprehensive coordination of care
by 1) appropriate specialists, 2) use of evidence-based therapies to
guide cancer prevention andmanagement decisions, and 3) integration
of palliative care and end-of-life counseling. In addition, the term
“quality cancer care” lacks a clear or consistent deﬁnition.
In June 2012, the Society of Gynecologic Oncology convened a
Practice Summit of thought leaders in the ﬁeld of gynecologic oncol-
ogy to assess the health care system and policy environment as they
pertain to the care of women with gynecologic cancers. During the
Summit, these leaders identiﬁed weaknesses of the current health
care system, devised solutions to the problems that SGO members
face in providing high quality, cost-effective care to women with gy-
necologic cancer, and proposed policy revisions that will affect the in-
corporation of these needed changes in the health care system. The
report, “Creating a New Paradigm in Gynecologic Cancer Care: Policy
Proposals for Delivery, Quality and Reimbursement,” is the result of
that effort. (The full report is available at sgo.org.)
The report addresses the following questions:
1) How should high quality gynecologic cancer care be delivered?
2) How should high quality gynecologic cancer care be better
deﬁned?
3) How should the delivery of high quality gynecologic cancer care
be fairly compensated?
Delivery systems
SGO proposes that the care of a woman with a suspected or diag-
nosed gynecologic cancer be structured like the patient-centered
medical home model and be coordinated by a single health care pro-
vider (a “team captain”) with multidisciplinary training in the care of
women with gynecologic cancer. We envision the team captain
directing a group of health care professionals, all working together
on behalf of the woman facing a gynecologic cancer diagnosis. These
professionals include radiation oncologists, medical oncologists, pain
and palliative care specialists, pathologists, radiologists and primary
care physicians; advanced practice providers; oncology nurses;
oncology pharmacists; genetic counselors; physical therapists; and
additional supportive care providers.http://dx.doi.org/10.1016/j.ygyno.2013.02.010
Open access under CC BY-NC-ND license.Deﬁning high quality gynecologic cancer care
It is essential that women uniformly receive early access to the
health care providers best qualiﬁed to care for women with gyneco-
logic cancer. Next, measurable standards for high quality care for
women diagnosed with gynecologic cancer must be determined, val-
idated and tracked. SGO proposes the expansion of a robust clinical
trials system for women with gynecologic cancer. A system that
holds providers accountable for delivering higher quality gynecologic
cancer care needs to be developed and tested based on these measur-
able standards. SGO calls for the use of demonstration projects, regis-
try systems and funding for outcomes-based research. Ultimately this
strategy lays the foundation for directing women with gynecologic
cancer to providers dedicated to providing guideline-based therapies,
for enhancing efforts to better measure quality outcomes, and to
incentivize providers to use this information for continuous and
real-time improvement in gynecologic cancer care.
Payment systems
The current reimbursement system for gynecologic cancer care is
cumbersome and not sustainable. It promotes disparities in gynecologic
cancer care and does not reward high quality care. To a large extent,
progress in the last decade in quality improvement projects has been
achieved by voluntary efforts of health care leaders backed by ﬁnancial
support from philanthropists. Any further quality improvements will
be unachievable with the current reimbursement model.
SGO proposes the development and testing of several payment
systems:
1) A diagnosis-based episode of care reimbursement system in which
payment would be based on each diagnostic episode of the
woman's illness, rather than on speciﬁc procedures.
2) A diagnostic episode bundled payment system with an incentive
for a team captain approach. This systemwould dispense a coordi-
nation fee for the team captain, distribute a percentage of the bun-
dled payments based upon involvement of team members in the
episode of care, and adjust payments based upon complexity of
care and co-morbidities.
3) A bundled approach with no team captain approach, in which
physicians would still bill for each diagnostic episode on a
per-patient basis, but there would be no concept of a team captain.
This approach may be suited for smaller or isolated communities
that lack the components of a coordinated care team.
4) A diagnosis-based episode bundled payments approach as a modi-
ﬁed capitation payment system. In this case, a gynecologic oncologist
4 Meeting Report from SGO Practice Summitwould be paid a monthly sum based on a historical number of pa-
tients cared for. Future Medicare payments would be based on the
number of patients seen in a year with a risk window of ±5 to 10%.
SGO also supports incentives for hospitals to become centers of
excellence in gynecologic oncology. Finally, fair compensation must
also be provided for care of complicated, benign gynecology and
obstetric patients.Conclusion
The solutions proposed by the SGO provide a roadmap towards
improving the quality of gynecologic cancer care, while reducing
costs associated with unnecessary testing and inappropriate thera-
pies. The SGO is committed to working with policy leaders to make
the changes needed in our health care system. Together we can
achieve meaningful reforms, rescue an economically unsustainable
medical system, and improve health care for women with gynecolog-
ic cancer. Our patients deserve no less.
Ronald D. Alvarez
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